Never Start a Batch Without an Authorized Manufacturing Order

Never Initiate Production Without an Authorized Manufacturing Order

Remember: Always ensure a manufacturing order is authorized before starting any GMP batch — unauthorized production violates documentation and traceability requirements.

Why This Matters in GMP

The manufacturing order is a foundational document in GMP production. It authorizes the batch, outlines approved processes, specifies material quantities, and defines parameters for execution. Initiating production without this authorization undermines batch traceability, quality assurance oversight, and regulatory compliance. Such unauthorized activity may result in the production of unvalidated or non-conforming material that cannot be released to market.

Consider a scenario where a production operator begins a blending step without formal approval. Any variation in raw material lot numbers, equipment ID, or process sequence would lack official documentation, making retrospective review impossible. This can lead to serious deviations, batch rejection, and even product recalls. The absence of a signed manufacturing order often reflects poor communication between planning, production, and QA — a breakdown that regulators view as a systemic control failure.

Also Read: Do Not Reuse Recovered Solvents Without Testing and GMP Documentation

Regulatory and Compliance Implications

Per 21 CFR Part 211.100, production and process control procedures must be written, followed, and documented. The manufacturing order serves as proof that a batch was executed

per approved instructions. EU GMP Chapter 4 and WHO GMP guidelines require all production steps to be pre-approved, traceable, and documented with real-time records.

Regulatory agencies scrutinize batch documentation during inspections. Starting a batch without authorization can lead to data integrity observations, audit findings, or even batch destruction. Unauthorized manufacturing may also be interpreted as an attempt to circumvent quality controls, a severe violation with potential legal implications. Furthermore, missing or backdated manufacturing orders raise red flags related to data falsification, which can affect a facility’s GMP status.

Also Read: Implement Color Coding for Product Status in GMP Warehouses

Implementation Best Practices

Establish strict controls ensuring that no manufacturing activity can begin without a QA-approved order. Use electronic or paper-based systems with lockout features that prevent printing or accessing batch records prior to authorization. Train production staff to verify authorization status before initiating any process step.

Document each step of the manufacturing order issuance and approval process, including timestamps, version control, and signatures. Conduct internal audits to verify compliance with manufacturing order workflows. Define clear escalation protocols for scenarios involving delayed approvals, changes in scheduling, or emergency manufacturing requests. Reinforce this compliance principle during onboarding and annual GMP training.

Regulatory References

– 21 CFR Part 211.100 – Written procedures; deviations
– EU GMP Chapter 4 – Documentation
– WHO TRS 986, Annex 2 – GMP for pharmaceutical products
– PIC/S PI 014 – GMP Guide for Manufacturing Authorization

Also Read: Use Air Curtains and Traps to Prevent Pest Entry into GMP Facilities